Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Apr 25, 2025

HUL Q4 Results Review: Systematix Remains Cautious On The Stock; Cuts Target Price, Maintaining 'Hold'

HUL Q4 Results Review: Systematix Remains Cautious On The Stock; Cuts Target Price, Maintaining 'Hold'
HUL's revenue /Ebitda/Adj.PAT growth of 2.4%/0.9%/3.8% YoY respectively led by 2% volume growth, with low-single digit growth in home care, beauty, personal care and slight decline in foods. (Photo Source: Sesa Sen/NDTV Profit)
STOCKS IN THIS STORY
Hindustan Unilever Ltd.
--

Gross margin decline of 140 basis points YoY to 50.5% was largely due to price hikes in soaps and tea lagging input-cost inflation in palm oil/ tea/ coffee; HUL indicated no further price cuts in Home Care, but expects GPMs to moderate near-term due to a persistent pricing-inflation gap.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Report

While Hindustan Unilever Ltd.'s volume pickup in key categories of detergents, dishwash, hair care, oral care and premium skin is encouraging, we remain cautious on persistent weakness in soaps, tea, mass skin and nutrition drinks.

We expect a gradual pickup in volume growth over FY26E-FY27E as HUL rejigs its portfolio to expand into high-growth categories (laundry/dishwash liquids, bodywash, international foods, high-science products in nutrition) and launches new product innovations to extract growth in portfolio gaps.

Realizations should benefit from-

  1. higher pricing in soaps and tea,

  2. normalization in detergents/ other categories and

  3. improving product mix/premiumization.

However, with near/medium-term margin outlook moderated in return for (expected) growth revival, we remain cautious on the stock.

We lower our FY26E-FY27E revenue estimates by c.2% but EPS estimates by a steeper c.10-11% to factor in the sharply lower operating profit margin outlook; we build revenue/PAT CAGR of 8%/6% over FY25-FY27E.

We maintain our Hold rating; we roll forward valuation to March-2027 (from December-2026) and value the stock at P/E of 49x (unchanged, a 15% discount to its long-period average to account for ongoing sluggish demand across key categories coupled with weaker margin outlook), leading to a lower target price of Rs 2,410 (versus Rs 2,645 earlier).

We await signs of improving outlook in areas of concern as well as stable margin trajectory before turning positive. Stock trades at P/E of 52x/47x on FY26E/FY27E EPS.

Click on the attachment to read the full report:

Systematix Hindustan Unilever - 4QFY25.pdf
VIEW DOCUMENT

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search